Cargando…
Treatments for early-stage Dupuytren’s disease: an evidence-based approach
Current treatments for Dupuytren’s disease are limited to late-stage disease when patients have developed flexion contractures and have impaired hand function. They all have limitations, including the risk of recurrence and complications. The use of treatments for early-stage disease, such as intral...
Autores principales: | Nanchahal, Jagdeep, Chan, James K.-K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996772/ https://www.ncbi.nlm.nih.gov/pubmed/36638105 http://dx.doi.org/10.1177/17531934221131373 |
Ejemplares similares
-
Systematic review of non-surgical treatments for early dupuytren’s disease
por: Ball, Catherine, et al.
Publicado: (2016) -
Recent advances in the understanding of Dupuytren’s disease
por: Layton, Thomas, et al.
Publicado: (2019) -
Optimal functional outcome measures for assessing treatment for Dupuytren’s disease: a systematic review and recommendations for future practice
por: Ball, Catherine, et al.
Publicado: (2013) -
Cost-effectiveness of adalimumab for early-stage Dupuytren’s disease: an economic evaluation based on a randomized controlled trial and individual-patient simulation model
por: Dakin, Helen, et al.
Publicado: (2022) -
What do we know about managing Dupuytren’s disease cost-effectively?
por: Dritsaki, Melina, et al.
Publicado: (2018)